Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Healthtrust
Farmers Insurance
QuintilesIMS
US Department of Justice
Citi
Cerilliant
Queensland Health

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,453,006

« Back to Dashboard

Which drugs does patent 9,453,006 protect, and when does it expire?

Patent 9,453,006 protects LUZU and is included in one NDA.

This patent has seven patent family members in five countries.
Summary for Patent: 9,453,006
Title:Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient
Abstract: Means for improving the solubility of luliconazole is provided. A crystal of luliconazole represented by the following formula is provided, wherein the crystal has such a crystal habit that (011) plane is a specific crystal growth plane. The crystal is characterized in that I.sub.(011) with respect to a sum total of I.sub.(001), I.sub.(100), I.sub.(10-1), I.sub.(011), I.sub.(110), I.sub.(11-1), I.sub.(10-2), I.sub.(11-2), I.sub.(020), I.sub.(021), I.sub.(20-2), I.sub.(121), I.sub.(013), I.sub.(11-3), and I.sub.(221) is not less than 25%, provided that integrated intensities of diffraction peaks, which correspond to the (001), (100), (10-1), (011), (110), (11-1), (10-2), (11-2), (020), (021), (20-2), (121), (013), (11-3), and (221) planes, are designated as I.sub.(001), I.sub.(100), I.sub.(10-1), I.sub.(011), I.sub.(110), I.sub.(11-1), I.sub.(10-2), I.sub.(11-2), I.sub.(020), I.sub.(021), I.sub.(20-2), I.sub.(121), I.sub.(013), I.sub.(11-3), and I.sub.(221) respectively in relation to the diffraction peaks detected in a range of 2.theta.=5 to 35.degree. in a powder X-ray diffractometry using CuK.alpha. radiation. ##STR00001##
Inventor(s): Masuda; Takaaki (Kanagawa, JP), Miyata; Yoshiyuki (Tokyo, JP), Kaneda; Hideo (Tokyo, JP)
Assignee: POLA PHARMA INC. (Tokyo, JP) NIHON NOHYAKU CO., LTD. (Tokyo, JP)
Application Number:14/388,218
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 9,453,006

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 9,453,006

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 105026390 ➤ Try a Free Trial
European Patent Office 2964641 ➤ Try a Free Trial
Japan 2014172858 ➤ Try a Free Trial
Japan 5589110 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cipla
Healthtrust
US Army
Accenture
Harvard Business School
US Department of Justice
Merck
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.